These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30745320)

  • 21. From Insight to Modulation of CXCR4 and ACKR3 (CXCR7) Function.
    Smit MJ; van Muijlwijk-Koezen JE
    Mol Pharmacol; 2019 Dec; 96(6):735-736. PubMed ID: 31624136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A taxonomy of organ-specific breast cancer metastases based on a protein-protein interaction network.
    Sanz-Pamplona R; García-García J; Franco S; Messeguer X; Driouch K; Oliva B; Sierra A
    Mol Biosyst; 2012 Aug; 8(8):2085-96. PubMed ID: 22710377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of CXCR7 inhibits proliferative capacity and stem cell-like properties in breast cancer stem cells.
    Tang X; Li X; Li Z; Liu Y; Yao L; Song S; Yang H; Li C
    Tumour Biol; 2016 Oct; 37(10):13425-13433. PubMed ID: 27460092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer.
    Wu W; Qian L; Chen X; Ding B
    Int J Clin Exp Pathol; 2015; 8(10):13217-24. PubMed ID: 26722521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial CXCR7 regulates breast cancer metastasis.
    Stacer AC; Fenner J; Cavnar SP; Xiao A; Zhao S; Chang SL; Salomonnson A; Luker KE; Luker GD
    Oncogene; 2016 Mar; 35(13):1716-24. PubMed ID: 26119946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer.
    Li JY; Ou ZL; Yu SJ; Gu XL; Yang C; Chen AX; Di GH; Shen ZZ; Shao ZM
    Breast Cancer Res Treat; 2012 Feb; 131(3):837-48. PubMed ID: 21479551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidermal growth factor-related peptides and their receptors in human malignancies.
    Salomon DS; Brandt R; Ciardiello F; Normanno N
    Crit Rev Oncol Hematol; 1995 Jul; 19(3):183-232. PubMed ID: 7612182
    [No Abstract]   [Full Text] [Related]  

  • 28. ShRNA-mediated knock-down of CXCR7 increases TRAIL-sensitivity in MCF-7 breast cancer cells.
    Gao W; Mei X; Wang J; Zhang X; Yuan Y
    Tumour Biol; 2015 Sep; 36(9):7243-50. PubMed ID: 25894375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of a chimeric chemokine as a specific ligand for ACKR3.
    Ameti R; Melgrati S; Radice E; Cameroni E; Hub E; Thelen S; Rot A; Thelen M
    J Leukoc Biol; 2018 Aug; 104(2):391-400. PubMed ID: 29601107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival.
    Feng LY; Ou ZL; Wu FY; Shen ZZ; Shao ZM
    Clin Cancer Res; 2009 May; 15(9):2962-70. PubMed ID: 19383822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. αv-Integrin isoform expression in primary human tumors and brain metastases.
    Vogetseder A; Thies S; Ingold B; Roth P; Weller M; Schraml P; Goodman SL; Moch H
    Int J Cancer; 2013 Nov; 133(10):2362-71. PubMed ID: 23661241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular characterization of CXCR-4: a potential brain tumor-associated gene.
    Sehgal A; Ricks S; Boynton AL; Warrick J; Murphy GP
    J Surg Oncol; 1998 Dec; 69(4):239-48. PubMed ID: 9881942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CXCR7 mediates TGFβ1-promoted EMT and tumor-initiating features in lung cancer.
    Wu YC; Tang SJ; Sun GH; Sun KH
    Oncogene; 2016 Apr; 35(16):2123-32. PubMed ID: 26212008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis.
    Urquidi V; Sloan D; Kawai K; Agarwal D; Woodman AC; Tarin D; Goodison S
    Clin Cancer Res; 2002 Jan; 8(1):61-74. PubMed ID: 11801541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting CXCR7 improves the efficacy of breast cancer patients with tamoxifen therapy.
    Hao M; Weng X; Wang Y; Sun X; Yan T; Li Y; Hou L; Meng X; Wang J
    Biochem Pharmacol; 2018 Jan; 147():128-140. PubMed ID: 29175422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis.
    Martinez-Ordoñez A; Seoane S; Cabezas P; Eiro N; Sendon-Lago J; Macia M; Garcia-Caballero T; Gonzalez LO; Sanchez L; Vizoso F; Perez-Fernandez R
    Oncogene; 2018 Mar; 37(11):1430-1444. PubMed ID: 29321662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An infernal trio: the chemokine CXCL12 and its receptors CXCR4 and CXCR7 in tumor biology.
    Hattermann K; Mentlein R
    Ann Anat; 2013 Mar; 195(2):103-10. PubMed ID: 23279723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Higher expression of chemokine receptor CXCR7 is linked to early and metastatic recurrence in pathological stage I nonsmall cell lung cancer.
    Iwakiri S; Mino N; Takahashi T; Sonobe M; Nagai S; Okubo K; Wada H; Date H; Miyahara R
    Cancer; 2009 Jun; 115(11):2580-93. PubMed ID: 19309748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of C-X-C chemokine receptor type 7 in otorhinolaryngologic neoplasms.
    Tang T; Xia QJ; Qiao X; Xi M
    Singapore Med J; 2016 Mar; 57(3):157-60. PubMed ID: 26996902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-132 prohibits proliferation, invasion, migration, and metastasis in breast cancer by targeting HN1.
    Zhang ZG; Chen WX; Wu YH; Liang HF; Zhang BX
    Biochem Biophys Res Commun; 2014 Nov; 454(1):109-14. PubMed ID: 25450365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.